Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification

Cited by (565)

Items 101–200 of 565

1. Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells
   Matti L. Gild, Iñigo Landa, Mabel M. Ryder, Ronald A. Ghossein, Jeffrey A. Knauf, James A. Fagin · 2013 · Endocrine Related Cancer
2. Targeting the pentose phosphate pathway increases reactive oxygen species and induces apoptosis in thyroid cancer cells
   Chien‐Liang Liu, Yi‐Chiung Hsu, Jie-Jen Lee, Ming‐Jen Chen, Chi‐Hsin Lin, Shih‐Yuan Huang, Shih‐Ping Cheng · 2019 · Molecular and Cellular Endocrinology
3. Gender differences in thyroid cancer: a critical review
   Reina Yao, Connie G. Chiu, Scott S. Strugnell, Sabrina Gill, Sam M. Wiseman · 2011 · Expert Review of Endocrinology & Metabolism
4. IQGAP1 Plays an Important Role in the Invasiveness of Thyroid Cancer
   Zhi Liu, Dingxie Liu, Ermal Bojdani, Adel K. El‐Naggar, Vasily V. Vasko, Mingzhao Xing · 2010 · Clinical Cancer Research
5. Short tandem repeat profiling: part of an overall strategy for reducing the frequency of cell misidentification
   Raymond W. Nims, Gregory Sykes, Karin Cottrill, Pranvera Ikonomi, Eugene L. Elmore · 2010 · In Vitro Cellular & Developmental Biology - Animal
6. The discovery and development of sorafenib for the treatment of thyroid cancer
   Peter T White, Mark Steven Cohen · 2015 · Expert Opinion on Drug Discovery
7. ZNF677 Suppresses Akt Phosphorylation and Tumorigenesis in Thyroid Cancer
   Yujun Li, Qi Yang, Haixia Guan, Bingyin Shi, Meiju Ji, Peng Hou · 2018 · Cancer Research
8. Widespread Use of Misidentified Cell Line KB (HeLa): Incorrect Attribution and Its Impact Revealed through Mining the Scientific Literature
   Vaughan, Liwen, Glänzel, Wolfgang, Korch, Christopher, Capes-Davis, Amanda · 2017 · Cancer Research
9. Copper Chelation as Targeted Therapy in a Mouse Model of Oncogenic BRAF-Driven Papillary Thyroid Cancer
   Mengmeng Xu, Michael Casio, Danielle Elliott Range, Julie Ann Sosa, Christopher M. Counter · 2018 · Clinical Cancer Research
10. Anti-inflammatory action of exendin-4 in human islets is enhanced by phosphodiesterase inhibitors: potential therapeutic benefits in diabetic patients
    Pugazhenthi, U., Velmurugan, K., Tran, A., Mahaffey, G., Pugazhenthi, S. · 2010 · Diabetologia
11. MiR-20a Is Upregulated in Anaplastic Thyroid Cancer and Targets LIMK1
    Yin Xiong, Lisa Zhang, Electron Kebebew · 2014 · PLoS ONE
12. Cancer stem-like cells and thyroid cancer
    Ziheng Guo, Haylee Hardin, Ricardo V. Lloyd · 2014 · Endocrine Related Cancer
13. A Novel Dual AMPK Activator/mTOR Inhibitor Inhibits Thyroid Cancer Cell Growth
    Robert L. Plews, Adlina Mohd Yusof, Chaojie Wang, Motoyasu Saji, Xiaoli Zhang, Ching‐Shih Chen, Matthew David Ringel, John E. Phay · 2015 · The Journal of Clinical Endocrinology & Metabolism
14. A novel RET inhibitor with potent efficacy against medullary thyroid cancer in vivo
    Samadi, Abbas K., Mukerji, Ridhwi, Shah, Anuj, Timmermann, Barbara N., Cohen, Mark S. · 2010 · Surgery
15. PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells
    Marialuisa Sponziello, Antonella Verrienti, Francesca Rosignolo, Roberta Francesca De Rose, Valeria Pecce, Valentina Maggisano, Cosimo Durante, Stefania Bulotta, Giuseppe Damante, Laura Giacomelli et al. · 2015 · Endocrine
16. Alternatively spliced isoforms of IL-32 differentially influence cell death pathways in cancer cell lines
    Bas Heinhuis, Theo S. Plantinga, George Semango, Benno Küsters, Mihai Gheorghe Netea, Charles Anthony Dinarello, Johannes W. A. Smit, Romana Teodora Netea-Maier, Leo A. B. Joosten · 2015 · Carcinogenesis
17. Dual inhibition of V600EBRAF and the PI3K/AKT/mTOR pathway cooperates to induce apoptosis in melanoma cells through a MEK-independent mechanism
    Irene Sánchez-Hernández, Pablo Baquero, Laura Calleros, Antonio Chiloeches · 2011 · Cancer Letters
18. Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasion
    Kevin Thomas Bauerle, Rebecca E. Schweppe, Bryan R. Haugen · 2010 · Molecular Cancer
19. Glucose-deprivation increases thyroid cancer cells sensitivity to metformin
    Athanasios Bikas, Kirk Ernest Jensen, Aneeta D. Patel, John M. Costello, Dennis P. McDaniel, Joanna Kłubo-Gwieździńska, О. С. Ларін, Victoria Hoperia, Kenneth Dale Burman, Lisa Boyle et al. · 2015 · Endocrine Related Cancer
20. RCAN1-4 is a thyroid cancer growth and metastasis suppressor
    Chaojie Wang, Motoyasu Saji, Steven E. Justiniano, Adlina Mohd Yusof, Xiaoli Zhang, Lianbo Yu, Soledad Fernández, Paul E. Wakely, Krista La Perle, Hiroshi Nakanishi et al. · 2017 · JCI Insight
21. The HuR CMLD-2 inhibitor exhibits antitumor effects via MAD2 downregulation in thyroid cancer cells
    Lorenzo Allegri, Federica Baldan, Sudeshna Roy, Jeffrey Aubé, Diego Russo, Sébastiano Filetti, Giuseppe Damante · 2019 · Scientific Reports
22. Nuclear Factor κB–Dependent Regulation of Angiogenesis, and Metastasis in an In Vivo Model of Thyroid Cancer Is Associated With Secreted Interleukin-8
    Kevin Thomas Bauerle, Rebecca E. Schweppe, Gregory S. Lund, Gregory R. Kotnis, Gagan Deep, Rajesh Agarwal, Nikita V. Pozdeyev, William M. Wood, Bryan R. Haugen · 2014 · The Journal of Clinical Endocrinology & Metabolism
23. SIRT7 promotes thyroid tumorigenesis through phosphorylation and activation of Akt and p70S6K1 via DBC1/SIRT1 axis
    Heng Li, Zhufang Tian, Yiping Qu, Qi Yang, Haixia Guan, Bingyin Shi, Meiju Ji, Peng Hou · 2018 · Oncogene
24. Implication of Nrf2 and ATF4 in differential induction of CHOP by proteasome inhibition in thyroid cancer cells
    Zhi‐Hong Zong, Zhen‐Xian Du, Ning Li, Chao Richard Li, Qiang Zhang, Bao-Qin Liu, Yifu Guan, Hua‐Qin Wang · 2012 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
25. STR DNA Typing of Human Cell Lines: Detection of Intra- and Interspecies Cross-Contamination
    Wilhelm Gerhard Dirks, Hans Günter Drexler · 2012 · Methods in molecular biology
26. Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status
    Martina Broecker‐Preuss, Stefan P Müller, Martin W. Britten, Karl Worm, Kurt Werner Schmid, Klaus Mann, Dagmar Führer · 2015 · BMC Cancer
27. MiR-886-3p Regulates Cell Proliferation and Migration, and Is Dysregulated in Familial Non-Medullary Thyroid Cancer
    Yin Xiong, Lisa Zhang, Alisha K. Holloway, Xiaolin Wu, Ling Su, Electron Kebebew · 2011 · PLoS ONE
28. Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo
    Maria Graziella Catalano, Mariateresa Pugliese, Eleonora Gargantini, Cristina Grange, Benedetta Bussolati, Sofia Asioli, Ornella Bosco, Roberta Poli, Alessandra Compagnone, Andrea Bandino et al. · 2011 · International Journal of Cancer
29. Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics
    Maria Nicoletta D’Agostino, Marialuisa Sponziello, Cinzia Puppin, Marilena Celano, Valentina Maggisano, Federica Baldan, Marco Biffoni, Stefania Bulotta, Cosimo Durante, Sébastiano Filetti et al. · 2013 · Journal of Molecular Endocrinology
30. Combining doxorubicin-nanobubbles and shockwaves for anaplastic thyroid cancer treatment: preclinical study in a xenograft mouse model
    Francesca Marano, Roberto Frairia, Letizia Rinella, Monica Argenziano, Benedetta Bussolati, Cristina Grange, Raffaella Mastrocola, Isabella Castellano, Laura Berta, Roberta Cavalli et al. · 2017 · Endocrine Related Cancer
31. Src-mediated regulation of the PI3K pathway in advanced papillary and anaplastic thyroid cancer
    Thomas C. Beadnell, Kelsey W. Nassar, Madison M. Rose, Erin G. Clark, Brian P. Danysh, Marie-Claude C. Hofmann, Nikita V. Pozdeyev, Rebecca E. Schweppe · 2018 · Oncogenesis
32. Expression and Biologic Significance of Adiponectin Receptors in Papillary Thyroid Carcinoma
    Shih‐Ping Cheng, Chien‐Liang Liu, Yi‐Chiung Hsu, Yuan‐Ching Chang, Shih‐Yuan Huang, Jie-Jen Lee · 2012 · Cell Biochemistry and Biophysics
33. A novel C-terminal HSP90 inhibitor KU135 induces apoptosis and cell cycle arrest in melanoma cells
    Abbas K. Samadi, Xuan Zhang, Ridhwi Mukerji, Alison C. Donnelly, Brian S. J. Blagg, Mark Steven Cohen · 2011 · Cancer Letters
34. CD74 expression and its therapeutic potential in thyroid carcinoma
    Shih‐Ping Cheng, Chien‐Liang Liu, Ming‐Jen Chen, Ming-Nan Chien, Ching-Hsiang Leung, Chi‐Hsin Lin, Yi‐Chiung Hsu, Jie-Jen Lee · 2015 · Endocrine Related Cancer
35. Lessons from Mouse Models of Thyroid Cancer
    Caroline S. Kim, Xuguang Zhu · 2009 · Thyroid
36. Down-regulation of 14q32-encoded miRNAs and tumor suppressor role formiR-654-3pin papillary thyroid cancer
    Murilo Vieira Geraldo, Helder Imoto Nakaya, Edna Teruko Kimura · 2016 · Oncotarget
37. Antiapoptotic Actions of Exendin-4 against Hypoxia and Cytokines Are Augmented by CREB
    Velmurugan, Kalpana, Balamurugan, A. N., Loganathan, Gopalakrishnan, Ahmad, Aftab, Hering, Bernhard J., Pugazhenthi, Subbiah · 2012 · Endocrinology
38. Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer
    Vahid Haghpanah, Parviz Fallah, Rezvan Tavakoli, Mahmood Naderi, Hilda Samimi, Masoud Soleimani, Bagher A. Larijani · 2015 · Tumor Biology
39. Cell Surface and Secreted Protein Profiles of Human Thyroid Cancer Cell Lines Reveal Distinct Glycoprotein Patterns
    Arthur Arcinas, Ten-Yang Yen, Electron Kebebew, Bruce A. Macher · 2009 · Journal of Proteome Research
40. Cancer Stem Cells in the Thyroid
    Yuji Nagayama, Mika Inada Shimamura, Norisato Mitsutake · 2016 · Frontiers in Endocrinology
41. Analysis of multiple markers for cancer stem-like cells in human thyroid carcinoma cell lines
    Mika Inada Shimamura, Yuji Nagayama, Michiko Matsuse, Shunichi Yamashita, Norisato Mitsutake · 2014 · Endocrine Journal
42. V600EBRAF promotes invasiveness of thyroid cancer cells by decreasing E-cadherin expression through a Snail-dependent mechanism
    Pablo Baquero, Irene Sánchez-Hernández, Eva Jiménez‐Mora, José Luis Orgaz, Benilde Jiménez, Antonio Chiloeches · 2013 · Cancer Letters
43. Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors
    Casimiro Luca Gigliotti, Benedetta Ferrara, Sergio Occhipinti, Elena Maria Boggio, Giuseppina Barrera, Stefania Pizzimenti, Mirella Giovarelli, Roberto Fantozzi, Annalisa Chiocchetti, Monica Argenziano et al. · 2017 · Drug Delivery
44. Preparation of 3-Substituted-1-Isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amines as RET Kinase Inhibitors
    Peter Dinér, John Patrick Alao, Johan Söderlund, Per Sunnerhagen, Morten Grøtli · 2012 · Journal of Medicinal Chemistry
45. Platelet‐derived growth factor receptor‐α promotes lymphatic metastases in papillary thyroid cancer
    Jingdong Zhang, Peng Wang, Mark A. Dykstra, Pascal Gélébart, David Williams, Robert J. Ingham, Esther Ekpe Adewuyi, Raymond L. Lai, Todd P W McMullen · 2012 · The Journal of Pathology
46. TBX1 Functions as a Tumor Suppressor in Thyroid Cancer Through Inhibiting the Activities of the PI3K/AKT and MAPK/ERK Pathways
    Na Wang, Yiqi Li, Jing Wei, Jun Pu, Rui Liu, Qi Yang, Haixia Guan, Bingyin Shi, Peng Hou, Meiju Ji · 2018 · Thyroid
47. The Emerging Cell Biology of Thyroid Stem Cells
    Terry F. Davies, Rauf Latif, Noga C. Minsky, Risheng Ma · 2011 · The Journal of Clinical Endocrinology & Metabolism
48. Histone Deacetylase Inhibition Affects Sodium Iodide Symporter Expression and Induces 131 I Cytotoxicity in Anaplastic Thyroid Cancer Cells
    Mariateresa Pugliese, Nicoletta Fortunati, Antonina Germano, Sofia Asioli, Francesca Marano, Nicola Palestini, Roberto Frairia, Giuseppe Boccuzzi, Maria Graziella Catalano · 2013 · Thyroid
49. Expression of haem oxygenase‐1 correlates with tumour aggressiveness and BRAF V 600E expression in thyroid cancer
    Tao‐Yeuan Wang, Chien‐Liang Liu, Ming‐Jen Chen, Jie-Jen Lee, Pou Chu Pun, Shih‐Ping Cheng · 2014 · Histopathology
50. Role of B-RafV600E in differentiated thyroid cancer and preclinical validation of compounds against B-RafV600E
    Carmelo Nucera, Melanie R. Goldfarb, Richard A. Hodin, Sareh Parangi · 2009 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
51. FOXO1 Controls Thyroid Cell Proliferation in Response to TSH and IGF-I and Is Involved in Thyroid Tumorigenesis
    Miguel Angel Zaballos, Pilar Santisteban · 2012 · Molecular Endocrinology
52. Sunitinib Inhibits MEK/ERK and SAPK/JNK Pathways and Increases Sodium/Iodide Symporter Expression in Papillary Thyroid Cancer
    Mike S. Fenton, Kenneth M. Marion, Andrew K. Salem, Rachel Hogen, Faramarz Naeim, Jerome M. Hershman · 2010 · Thyroid
53. Antiproliferative Effect of Chrysin on Anaplastic Thyroid Cancer
    Tramanh Phan, Xiao-Min Yu, Muthusamy Kunnimalaiyaan, Herbert Chen · 2011 · Journal of Surgical Research
54. MCM5 as a target of BET inhibitors in thyroid cancer cells
    Catia Mio, Elisa Lavarone, Ketty Conzatti, Federica Baldan, Barbara Toffoletto, Cinzia Puppin, Sébastiano Filetti, Cosimo Durante, Diego Russo, Arturo Orlacchio et al. · 2016 · Endocrine Related Cancer
55. Estrogen receptor subtype expression and regulation is altered in papillary thyroid cancer after menopause
    Gustavo A. Rubio, Paola Catanuto, Marilyn K. Glassberg, John I. Lew, Sharon J. Elliot · 2017 · Surgery
56. Thyroid Stem Cells and Cancer
    Thomas C. Klonisch, Cuong Hoang‐Vu, Sabine Hombach‐Klonisch · 2009 · Thyroid
57. Activation of the RAS/RAF/ERK Signaling Pathway Contributes to Resistance to Sunitinib in Thyroid Carcinoma Cell Lines
    Annamaria Piscazzi, Eleonora Costantino, Francesca Maddalena, Maria Iole Natalicchio, Assunta Maria Teresa Gerardi, Raffaele Antonetti, Mauro Cignarelli, Matteo Landriscina · 2012 · The Journal of Clinical Endocrinology & Metabolism
58. AZD1152 negatively affects the growth of anaplastic thyroid carcinoma cells and enhances the effects of oncolytic virus dl922-947
    Silvana Libertini, Antonella Abagnale, Carmela Passaro, Ginevra Botta, Simona Barbato, Paolo Chieffi, Giuseppe Portella · 2010 · Endocrine Related Cancer
59. Phenotypic Characterization of Metastatic Anaplastic Thyroid Cancer Stem Cells
    Wen Li, Ashley N. Reeb, William A. Sewell, George Elhomsy, Reigh-Yi Lin · 2013 · PLoS ONE
60. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy
    Honey V. Reddi, Pranathi Madde, Samantha J. McDonough, M A Trujillo, J C Morris, Rae M. Myers, Kah-Whye Peng, Stephen J. Russell, Bryan McIver, Norman L. Eberhardt · 2012 · Cancer Gene Therapy
61. Histone Deacetylase Inhibition Modulates E-Cadherin Expression and Suppresses Migration and Invasion of Anaplastic Thyroid Cancer Cells
    Maria Graziella Catalano, Nicoletta Fortunati, Mariateresa Pugliese, Francesca Marano, Loredana Ortoleva, Roberta Poli, Sofia Asioli, Andrea Bandino, Nicola Palestini, Cristina Grange et al. · 2012 · The Journal of Clinical Endocrinology & Metabolism
62. A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer
    Shu‐Fu Lin, Jen‐Der Lin, Chuen Hsueh, Ting‐Chao Chou, Richard J. Wong · 2017 · PLoS ONE
63. A ceRNA Circuitry Involving the Long Noncoding RNA Klhl14-AS, Pax8, and Bcl2 Drives Thyroid Carcinogenesis
    Sara Carmela Credendino, Maria L. Bellone, Nicole Lewin, Elena Amendola, Remo Sanges, Swaraj Basu, Romina Sepe, Myriam Decaussin‐Petrucci, Nadia Tinto, Alfredo Fusco et al. · 2019 · Cancer Research
64. Epigenetics Modifications and Therapeutic Prospects in Human Thyroid Cancer
    Maria Graziella Catalano, Nicoletta Fortunati, Giuseppe Boccuzzi · 2012 · Frontiers in Endocrinology
65. RETRACTED ARTICLE: Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer
    Daniel Boon Yeow Chan, Yun Zheng, Jeffrey W Tyner, Wee Joo Chng, Wen Wen Chien, Sigal Gery, Geraldine Leong, Glenn David Braunstein, Harold Phillip Koeffler · 2013 · Journal of Cancer Research and Clinical Oncology · Retracted
66. EGFR/MEK/ERK/CDK5-dependent integrin-independent FAK phosphorylated on serine 732 contributes to microtubule depolymerization and mitosis in tumor cells
    Katia Rea, Marialuisa Sensi, Andrea Anichini, S. Canevari, Antonella Tomassetti · 2013 · Cell Death and Disease
67. Activation of the Sonic Hedgehog pathway in thyroid neoplasms and its potential role in tumor cell proliferation
    Xiulong Xu, Helen G. Ding, Geetha Rao, Shalini Arora, Constantine Saclarides, Joseph R. Esparaz, Paolo Gattuso, Carmen C. Solórzano, Richard A. Prinz · 2012 · Endocrine Related Cancer
68. Iodide Transporter NIS Regulates Cancer Cell Motility and Invasiveness by Interacting with the Rho Guanine Nucleotide Exchange Factor LARG
    Claire Lacoste, Julie Hervé, Myriam Bou Nader, Alexandre Dos Santos, Nicolas Moniaux, Yannick Valogne, Rodrick Montjean, Olivier Dorseuil, Didier Samuel, Doris Cassio et al. · 2012 · Cancer Research
69. 1,25 dihydroxyvitamin D3 inhibits the proliferation of thyroid cancer stem-like cells via cell cycle arrest
    Wen Huang Peng, Kun Wang, Rendong Zheng, Michael Derwahl · 2016 · Endocrine Research
70. Combined Anti-Angiogenic Therapy Targeting PDGF and VEGF Receptors Lowers the Interstitial Fluid Pressure in a Murine Experimental Carcinoma
    Agnieszka Kłosowska‐Wardęga, Yoko Hasumi, Mikhail Burmakin, Aive Åhgren, Linda E. B. Stuhr, Ingrid Nyhus Moen, Rolf Kåre Reed, Kristofer Rubin, Carina B. Hellberg, Carl‐Henrik Heldin · 2009 · PLoS ONE
71. Utility of a Histone Deacetylase Inhibitor (PXD101) for Thyroid Cancer Treatment
    Shu‐Fu Lin, Jen‐Der Lin, Ting‐Chao Chou, Yu‐Yao Huang, Richard J. Wong · 2013 · PLoS ONE
72. Effects of nutraceuticals on anaplastic thyroid cancer cells
    Lorenzo Allegri, Francesca Rosignolo, Catia Mio, Sébastiano Filetti, Federica Baldan, Giuseppe Damante · 2017 · Journal of Cancer Research and Clinical Oncology
73. The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid Cancer Cells
    Oorvashi Roy Puli, Brian P. Danysh, Elena McBeath, Deepankar K Sinha, Nguyet Minh Hoang, Reid Trenton Powell, Heather E. Danysh, Maria E. Cabanillas, Gilbert J. Cote, Marie-Claude C. Hofmann · 2018 · Neoplasia
74. Incidences of problematic cell lines are lower in papers that use RRIDs to identify cell lines
    Babic, Zeljana, Capes-Davis, Amanda, Martone, Maryann E, Bairoch, Amos, Ozyurt, I Burak, Gillespie, Thomas H, Bandrowski, Anita E · 2019 · eLife
75. Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion
    Samantha McCarty, Motoyasu Saji, Xiaoli Zhang, David G. Jarjoura, Alfredo Fusco, Vasyl V. Vasko, Matthew David Ringel · 2010 · Endocrine Related Cancer
76. Utility of a PI3K/mTOR Inhibitor (NVP-BEZ235) for Thyroid Cancer Therapy
    Shu‐Fu Lin, Yu‐Yao Huang, Jen‐Der Lin, Ting‐Chao Chou, Chuen Hsueh, Richard J. Wong · 2012 · PLoS ONE
77. mTOR Inhibition Promotes TTF1-Dependent Redifferentiation and Restores Iodine Uptake in Thyroid Carcinoma Cell Lines
    Theo S. Plantinga, Bas Heinhuis, Danny Gerrits, Mihai Gheorghe Netea, Leo A. B. Joosten, Ad R. Hermus, Wim J.G. Oyen, Rebecca E. Schweppe, Bryan R. Haugen, Otto C. Boerman et al. · 2014 · The Journal of Clinical Endocrinology & Metabolism
78. Aberrant Thyroid-Stimulating Hormone Receptor Signaling Increases VEGF-A and CXCL8 Secretion of Thyroid Cancer Cells, Contributing to Angiogenesis and Tumor Growth
    Young Shin Song, Min Joo Kim, Hyun Jin Sun, Hwan Hee Kim, Hyo Shik Shin, Young A Kim, Byung‐Chul Oh, Sun Wook Cho, Young Joo Park · 2018 · Clinical Cancer Research
79. Reprogramming of Energy Metabolism: Increased Expression and Roles of Pyruvate Carboxylase in Papillary Thyroid Cancer
    Aurélie Strickaert, Cyril Corbet, Selim Alex Spinette, Ligia Craciun, Geneviève Dom, Guy Andry, Denis Larsimont, Ruddy Wattiez, Jacques E. Dumont, Olivier Féron et al. · 2019 · Thyroid
80. Expression of cancer stem cell markers and epithelial-mesenchymal transition-related factors in anaplastic thyroid carcinoma.
    Chang Won Jung, Kang Hee Han, Hyesil Seol, Sunhoo Park, Jae Soo Koh, Seung‐Sook Lee, Min Joo Kim, Ik Joon Choi, Jae Kyung Myung · 2015 · Europe PMC (PubMed Central)
81. Anti-hTERT siRNA-Loaded Nanoparticles Block the Growth of Anaplastic Thyroid Cancer Xenograft
    Giovanni Enrico Lombardo, Valentina Maggisano, Marilena Celano, Donato Cosco, Chiara Mignogna, Federica Baldan, Saverio Massimo Lepore, Lorenzo Allegri, Sonia Moretti, Cosimo Durante et al. · 2018 · Molecular Cancer Therapeutics
82. TWIST1 Plays a Pleiotropic Role in Determining the Anaplastic Thyroid Cancer Phenotype
    Paolo Salerno, Ginesa García‐Rostán, Sara Piccinin, Tammaro Claudio Bencivenga, Gennaro Di Maro, Claudio Doglioni, Fulvio Basolo, Roberta Maestro, Alfredo Fusco, Massimo Mattia Santoro et al. · 2011 · The Journal of Clinical Endocrinology & Metabolism
83. Conventional and molecular cytogenetics of human non-medullary thyroid carcinoma: characterization of eight cell line models and review of the literature on clinical samples
    Franclim R. Ribeiro, Ana Margarida Meireles, Ana Sofia Rocha, Manuel Rodrigues Teixeira · 2008 · BMC Cancer
84. FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma
    Roberto Bellelli, Maria Domenica Castellone, Ginesa García‐Rostán, Clara Ugolini, Carmelo Nucera, Peter M. Sadow, Tito Claudio Nappi, Paolo Salerno, Maria Carmela Cantisani, Fulvio Basolo et al. · 2012 · Endocrine Related Cancer
85. Gemcitabine-Loaded Biocompatible Nanocapsules for The Effective Treatment of Human Cancer
    Donatella Paolino, Donato Cosco, Marilena Celano, Sonia Moretti, Efisio Puxeddu, Diego Russo, Massimo Fresta · 2012 · Nanomedicine
86. Sorafenib and Quinacrine Target Anti-Apoptotic Protein MCL1: A Poor Prognostic Marker in Anaplastic Thyroid Cancer (ATC)
    Junaid Abdulghani, Prashanth Ravishankar Gokare, Jean‐Nicolas Gallant, David T. Dicker, Tiffany L. Whitcomb, Timothy K. Cooper, Jiangang Liao, Jonathan B. Derr, Jing Liu, David Goldenberg et al. · 2016 · Clinical Cancer Research
87. Heme Oxygenase-1 Inhibitors Induce Cell Cycle Arrest and Suppress Tumor Growth in Thyroid Cancer Cells
    Po-Sheng Yang, Yi‐Chiung Hsu, Jie-Jen Lee, Ming‐Jen Chen, Shih‐Yuan Huang, Shih‐Ping Cheng · 2018 · International Journal of Molecular Sciences
88. MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting NF2 in Human Papillary Thyroid Cancer
    Chunxiao Yu, Li Zhang, Dandan Luo, Fang Yan, Jia Liu, Shanshan Shao, Lifang Zhao, Tong Jin, Jiajun Zhao, Ling Gao · 2018 · Thyroid
89. The Aryl Hydrocarbon Receptor Is Expressed in Thyroid Carcinoma and Appears to Mediate Epithelial-Mesenchymal-Transition
    Sonia Moretti, Nicole Nucci, Elisa Menicali, Silvia Morelli, Vittorio Bini, Renato Colella, Martina Mandarano, Angelo Sidoni, Efisio Puxeddu · 2020 · Cancers
90. Wnt/β-Catenin Signaling Pathway Is a Direct Enhancer of Thyroid Transcription Factor-1 in Human Papillary Thyroid Carcinoma Cells
    Marie Gilbert-Sirieix, Joelle Makoukji, Shioko Kimura, Monique Talbot, Bernard Caillou, Charbel Massaad, Liliane Massaad-Massade · 2011 · PLoS ONE
91. XB130, a New Adaptor Protein, Regulates Expression of Tumor Suppressive MicroRNAs in Cancer Cells
    Hiroki Takeshita, Atsushi Shiozaki, Xiao-Hui Bai, Daisuke Iitaka, Hyunhee Kim, Burton B. Yang, Shaf H Keshavjee, Mingyao Liu · 2013 · PLoS ONE
92. ABI3 ectopic expression reduces in vitro and in vivocell growth properties while inducing senescence
    Latini, Flavia RM, Hemerly, Jefferson P, Freitas, Beatriz CG, Oler, Gisele, Riggins, Gregory J, Cerutti, Janete M · 2011 · BMC Cancer
93. SP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on ROCK and p53 pathways
    Elisa Grassi, Valeria Vezzoli, Irene Negri, Árpád Lábadi, Laura Fugazzola, Giovanni Vitale, Luca Persani · 2015 · Oncotarget
94. Secretome-Based Identification and Characterization of Potential Biomarkers in Thyroid Cancer
    Lawrence Kashat, Anthony K.-C. So, Olena Masui, X. Simon Wang, Jun Cao, Xianwang Meng, Christina MacMillan, Laurie Ailles, K. W. Michael Siu, Ranju Ralhan et al. · 2010 · Journal of Proteome Research
95. Coexpression of EpCAM, CD44 Variant Isoforms and Claudin-7 in Anaplastic Thyroid Carcinoma
    Toshihiro Okada, Teruo Nakamura, Takayuki Watanabe, Naoyoshi Onoda, Atsuko Ashida, Ryuhei Okuyama, Ken‐ichi Ito · 2014 · PLoS ONE
96. Inhibition of pituitary tumor‐transforming gene‐1 in thyroid cancer cells by drugs that decrease specificity proteins
    Sudhakar R. Chintharlapalli, Sabitha Papineni, Syng‐Ook Lee, Ping Lei, Un Ho Jin, Steven I. Sherman, Libero Santarpia, Stephen H Safe · 2011 · Molecular Carcinogenesis
97. PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms
    Arianna Nicolussi, Sonia D'inzeo, Gabriella Mincione, Amelia Buffone, Maria Carmela Di Marcantonio, Roberto Cotellese, Annadomenica Cichella, Carlo Capalbo, Cira Rosaria Tiziana Di Gioia, FRANCESCO NARDI et al. · 2013 · International Journal of Oncology
98. Efficacy of an HSP90 inhibitor, ganetespib, in preclinical thyroid cancer models
    Shu‐Fu Lin, Jen‐Der Lin, Chuen Hsueh, Ting‐Chao Chou, Chun‐Nan Yeh, Minghuang Chen, Richard J. Wong · 2017 · Oncotarget
99. Effects of different extracts of curcumin on TPC1 papillary thyroid cancer cell line
    Angelica Perna, Antonio De Luca, Laura Adelfi, Tammaro Pasquale, Bruno Varriale, Teresa Esposito · 2018 · BMC Complementary and Alternative Medicine
100. Recurrence of Papillary Thyroid Cancer: A Systematic Appraisal of Risk Factors
     Hannah R. Nieto, Caitlin E.M. Thornton, Katie Brookes, Albert Nobre de Menezes, Alice Fletcher, Mohammed Alshahrani, Merve Kocbiyik, Neil Sharma, Kristien Boelaert, Jean‐Baptiste Cazier et al. · 2021 · The Journal of Clinical Endocrinology & Metabolism